Ligand · SUE
SUE · (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-di oxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadec ino[11,12-b]quinoxaline-8-carboxamide
SUE, (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-di…
- Component
- SUE
- Formula
- C38 H50 N6 O9 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
SUE in 2 structures; the first of them:
- 6C2M · Crystal structure of HCV NS3/4A protease variant Y56H in complex with MK-5172 · SUE A1202 · binds GLN1041, THR1042, PHE1043, VAL1055, HIS1056, HIS1057, GLY1058, VAL1078 and 14 more
- 6P6Q · HCV NS3/4A protease domain of genotype 1a3a chimera in complex with grazoprevir · SUE A1301 · binds GLN1041, THR1042, PHE1043, TYR1056, HIS1057, GLY1058, VAL1078, ASP1081 and 12 more
Residues it binds most
SER 6, VAL 6, ALA 6, GLY 6, PHE 6, ARG 6, HIS 6, ASP 6, GLN 6, LEU 6 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.